Title Credit Start and expiration dates Member pricesort descending Non-member price
Adolescent Suicide Risk Assessment

1.25 NAPNAP Contact Hour 0 Pharmacology Hours This course will help to identify youth at risk for suicide in your practice. It focuses on the assessment of background and subjective risk factors using the well-known HEADSS (Home, Education, Activities, Drug use and abuse, Sexual behavior, and Suicidality) interview instrument for psycho-social risk assessment.

  • 1.25 Contact hours
01/01/2014 to 12/31/2018 $0.00 $0.00
Management of Childhood Functional Constipation

1.0 Contact Hour and 0.5 Pharmacology.  Constipation is a common problem during childhood, and 0.7% to 29.6% of children are constipated worldwide. This condition accounts for 3% to 5% of pediatric primary care visits and up to 25% of gastroenterology consultations. Children presenting to the emergency department with abdominal pain are most often diagnosed with constipation. Nearly all childhood constipation is functional, but 5% to 10% is due to an organic cause.

  • 1.00 Contact hours
12/28/2017 to 02/28/2019 $0.00 $10.00
Bullying: What the PNP Needs to Know
Despite generations of doubt about the true impact of bullying, it is now clear that childhood bullying can have significant lifelong consequences for victims and bullies alike. Recent school shootings and suicides by students who have been victims of bullying have helped to solidify public awareness of the gravity of the problem of childhood bullying. Adults who were frequently bullied in childhood have an increased frequency of psychiatric disorders, including anxiety, depression, and suicidality, extending into middle age.Bullying is clearly a pediatric health care problem. This continuing education article will explore bullying in terms of definitions, epidemiology, types, risk factors, resilience factors, consequences, and implications for practice. J Pediatr Health Care. (2018)
  • 1.00 Contact hours
06/22/2018 to 06/28/2019 $0.00 $10.00
The Nurse Practitioner's Role in Evaluation of Children and Adolescents with Gastroenterology Concerns

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.5 NAPNAP contact hours, of which 0.25 is pharmacology content.

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org

  • 1.50 Contact hours
07/06/2017 to 12/31/2018 $0.00 $0.00
New Approaches to the Use of Antibiotics
We all recognize the widespread development to antibiotic resistance within our practices; pharma's antibiotic pipeline is dwindling, technology and guidelines are evolving, and duration of therapy is changing. This course will review where we were, discuss where we are now, and (with the help of a cloudy crystal ball), attempt to analyze how we need to proceed in the coming years of increasing antimicrobial resistance. 1.0 NAPNAP Contact Hour, 1.0 Pharmacology Hour
  • 1.00 Contact hours
06/26/2018 to 06/30/2019 $0.00 $0.00
Human Trafficking 101

Up to 87 percent of human trafficking victims have encountered a healthcare professional without being identified. Now is your chance to learn about human trafficking, especially related to children, adolescents and teens, so you are ready to help a victim in your practice setting. Don’t be fooled – trafficking happens in every state and every community. Human Trafficking 101, educates participants about this $32 billion criminal industry and its prevalence in all communities and sectors of our society. Participants will also learn how to recognize the signs of human trafficking in child victims and understand situations and challenges that make kids susceptible to trafficking predators. 

  • 1.50 Contact hours
01/01/2018 to 10/01/2019 $0.00 $15.00
Newborn Screening for Lysosomal Storage Disorders
1.0 NAPNAP Contact hour, 0.5 Rx hours. Lysosomal storage disorders (LSDs) are a heterogeneous group of approximately 50 rare inheritedmetabolic conditions that result from enzyme deficiencies that interfere with lysosome function. Although often grouped together, there is great variability regarding age of onset, severity, treatment, and outcomes for each disorder and subtype. Currently, laboratory methods are available to test newborns for seven of these conditions. Although newborn screening programs remain state-based, each at a different phase of condition review and implementation, if newborn screening for LSDs has not yet been adopted by the state within which you practice, it likely will. Given the extremely low prevalence and limited provider familiarity with these conditions, this article provides an overview of LSDs and the seven conditions for which newborn screening is available. It offers information about each of the conditions including enzyme deficiency, mode of inheritance, incidence rates, types, clinical course, and available as well as potential treatment options. J Pediatr Health Care. (2018) 32, 285-294.KEY
  • 1.00 Contact hours
04/16/2018 to 06/30/2019 $0.00 $10.00
Juvenile Idiopathic Arthritis: A Focus on Pharmacologic Management
1.50 NAPNAP Contact Hour of which 1.50 contain Pharmacology content. Juvenile idiopathic arthritis is a chronic condition that affects many pediatric patients. It is a prevalent disease and has become the most common rheumatologic disease of childhood. The condition encompasses multiple different forms of chronic arthritides classified based on the location and number of joints affected as well as the presence or lack of a number of different inflammatory markers. The exact etiology is unknown but is thought to be multifactorial with genetic, humoral, and environmental factors playing a keyrole. Many pharmacologic agents are available for use in the treatment of juvenile idiopathic arthritis, with management involving the use of symptom-reducing agents and diseasemodifying antirheumatic drugs. Treatment is not without adverse events, with many of the agents require monitoring regimens and patient education. Without treatment, the progression and chronicity of the disease can result in significant morbidity, with the potential for devastating consequences on the child’s quality of life. J Pediatr HealthCare. (2018)
  • 1.50 Contact hours
08/13/2018 to 09/01/2019 $0.00 $10.00
Celiac Disease in the Pediatric Population
0.25 NAPNAP Contact hours. Celiac disease is an autoimmune disorder in which the lining of the gastrointestinal tract is damaged by an immunemediated response to gluten proteins (Allen, 2015). It is a polygenetic disease that only appears in genetically susceptible individuals (Newton & Singer, 2012). Celiac disease can present in a spectrum of manifestations, making it difficult to identify and diagnosis. Currently, the only treatment for celiac disease is a strict, gluten-free diet. Further research is warranted in areas of environmental risk factors and treatments (Allen, 2015; Newton & Singer, 2012). J Pediatr Health Care. (2018)
  • 0.25 Contact hours
10/17/2018 to 10/31/2019 $0.00 $10.00
Asthma Essentials
This course will describe ways nurse practitioners can incorporate EPR-3 clinical guidelines for asthma, using EPR-3 tables to guide care decisions in asthma management. Participants will receive information on essential asthma tools to improve asthma care (digital flow meters to measure lung function and the In-Check Dial to assess/coach inhaler technique); age appropriate techniques to improve inhalation and delivery of inhaled medicines; key asthma messages to deliver to patients/families; and guidelines for reimbursement in asthma care. Participants will identify key action steps for improving asthma care and gain confidence to identify, assess and monitor their patients with asthma.1.25 NAPNAP Contact Hour, 0.25 Pharmacology Hour
  • 1.25 Contact hours
05/09/2018 to 05/31/2019 $0.00 $0.00
Immunizations 2018
Immunization recommendations are updated annually by the CDC. This course will advise NPs about the most current information in pediatric and adolescent immunizations using case studies. The recommended schedule, clarification of the guidelines, newly licensed vaccines and current controversies will be emphasized. 1 NAPNAP Contact Hour, 1 Pharmacology Hour
  • 1.00 Contact hours
05/18/2018 to 05/31/2019 $0.00 $10.00
Pathophysiology and Management of Mild to Moderate Pediatric Atopic Dermatitis Journal Supplement

1.0 NAPNAP Contact Hour of which 0.5 contain pharmacology. This CE-certified journal supplement will address several important clinical practice gaps related to atopic dermatitis, including current knowledge of inflammatory pathways that contribute to disease pathogenesis, appropriate and effective use of currently available therapies, and patient/caregiver education strategies for the management of mild to moderate atopic dermatitis.

  • 1.00 Contact hours
02/26/2018 to 03/01/2019 $0.00 $0.00
Early Detection and Aggressive Management of Otologic Pathologies in Children with Down Syndrome
This course will review the current recommendations and guidelines related to otologic disease in children with DS. Topics covered will include an overview of the pathologies and etiologies; screening and evaluation guidelines; management options; and the role of the Nurse Practitioner in the primary care setting and beyond. 0.25 NAPNAP Contact Hour, 0 Pharmacology Hour
  • 0.25 Contact hours
05/07/2018 to 05/31/2020 $2.50 $5.00
Concussion
0.25 NAPNAP Contact Hour 0 Pharmacology Hours This course will discuss management of concussions.
  • 0.25 Contact hours
12/08/2016 to 12/31/2018 $2.50 $5.00
Telephone Triaging
0.25 NAPNAP Contact Hour 0 Pharmacology Hours This course will discuss telephone triage pitfalls.
  • 0.25 Contact hours
12/08/2016 to 12/31/2018 $2.50 $5.00

Pages